Raea Michie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Raea Michie has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Alannah Hyland
Karolinska Institute
1 shared publication- Alda Saldan
Department of Molecular Medicine, University of Padua, Padua, Italy
1 shared publication - Ann-Sophie Oppelt
Karolinska Institute
1 shared publication - Anna Pumpe
Karolinska Institute
1 shared publication - Arnika Kathleen Wagner
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Benedict J. Chambers
Karolinska Institutet
1 shared publication
Latest Publications
- Open Access
Intratumoral expression of JAML on NK cells is controlled by tumor microenvironment and MHC class I interaction
JAML is an adhesion molecule known to promote T cell activation and T cell-mediated tumor rejection. In the current study, we show that JAML expression is enriched on mouse intratumoral NK cells compared with splenic NK cells. JAML+ NK cells were associated with tissue residency and co-expressed the immune checkpoints PD-1 and LAG3. JAML expression could be induced on splenic NK cells by IL-2 and further enhanced by IL-21. JAML levels were inversely correlated with inhibitory signaling, as NK cells expressing self-recognizing Ly49 receptors had reduced JAML expression, suggesting regulation of JAML expression by MHC class I molecules. Interaction with the JAML ligand CXADR also reduced JAML surface expression, indicating that tumor-mediated membrane stripping may represent a mechanism of immunoediting. Although JAML RNA transcripts were detectable in human NK cells, JAML protein was found only intracellularly. Together, these findings identify the JAML-CXADR interaction as a potential regulatory pathway in NK cell-mediated killing of tumors.
Open AccessIntratumoral expression of JAML on NK cells is controlled by tumor microenvironment and MHC class I interaction
JAML is an adhesion molecule known to promote T cell activation and T cell-mediated tumor rejection. In the current study, we show that JAML expression is enriched on mouse intratumoral NK cells compared with splenic NK cells. JAML+ NK cells were associated with tissue residency and co-expressed the immune checkpoints PD-1 and LAG3. JAML expression could be induced on splenic NK cells by IL-2 and further enhanced by IL-21. JAML levels were inversely correlated with inhibitory signaling, as NK cells expressing self-recognizing Ly49 receptors had reduced JAML expression, suggesting regulation of JAML expression by MHC class I molecules. Interaction with the JAML ligand CXADR also reduced JAML surface expression, indicating that tumor-mediated membrane stripping may represent a mechanism of immunoediting. Although JAML RNA transcripts were detectable in human NK cells, JAML protein was found only intracellularly. Together, these findings identify the JAML-CXADR interaction as a potential regulatory pathway in NK cell-mediated killing of tumors.